Aethlon Medical, Inc. entered into a Securities Purchase Agreement on July 6, 2026, to conduct a registered public offering. The company issued 263,000 shares of common stock, 5,633,009 common warrants, and 5,370,009 pre-funded warrants at a combined price of $0.71 per unit. The offering closed on July 7, 2026, generating approximately $4.0 million in gross proceeds and approximately $3.335 million in net proceeds after paying Maxim Group LLC a 6.25% cash fee and expense reimbursements. Net proceeds are intended for general working capital. Aethlon Medical, Inc. is a medical technology company.
